Advair
Chasing Mylan, Hikma tries again with rejected generic Advair in US
Phil Taylor
Advair, asthma, Chronic Obstructive Pulmonary Disease, generic, GlaxoSmithKline, Hikma, Mylan, respiratory, Sandoz
0 Comment
News/ News/ Sales and Marketing
Shingrix and Trelegy shield GSK from Advair fallout
Phil Taylor
Advair, financial results, GlaxoSmithKline, Nucala, Shingrix, Trelegy
0 Comment
News/ News/ Sales and Marketing
Shingles vaccine boosts GSK as generic Advair bites
George Underwood
Advair, GlaxoSmithKline, GSK, Q1, Shingrix
0 Comment
Healthcare/ Market Access/ News/ News/ Top stories/ UK & Europe
Advair reprieve gives GSK breathing space
GSK’s new pharma chief Miels to join in September
Richard Staines
Advair, GSK, Luke Miels
0 Comment
Luke Miels to start role after GSK and AZ end contract row.